Cargando…

Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterised by neuropathological deposits of amyloid plaques and neurofibrillary tangles comprised of β-amyloid and tau protein, respectively. In AD, tau becomes abnormally phosphorylated and aggregates to form intracellular depo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lau, Dawn H. W., Hogseth, Marte, Phillips, Emma C., O’Neill, Michael J., Pooler, Amy M., Noble, Wendy, Hanger, Diane P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870772/
https://www.ncbi.nlm.nih.gov/pubmed/27193083
http://dx.doi.org/10.1186/s40478-016-0317-4
_version_ 1782432495476670464
author Lau, Dawn H. W.
Hogseth, Marte
Phillips, Emma C.
O’Neill, Michael J.
Pooler, Amy M.
Noble, Wendy
Hanger, Diane P.
author_facet Lau, Dawn H. W.
Hogseth, Marte
Phillips, Emma C.
O’Neill, Michael J.
Pooler, Amy M.
Noble, Wendy
Hanger, Diane P.
author_sort Lau, Dawn H. W.
collection PubMed
description Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterised by neuropathological deposits of amyloid plaques and neurofibrillary tangles comprised of β-amyloid and tau protein, respectively. In AD, tau becomes abnormally phosphorylated and aggregates to form intracellular deposits. However, the mechanisms by which tau exerts neurotoxicity in disease remain unclear. Recent studies have suggested that the presence of tau at synapses may indicate a role in neuronal signalling, which could be disrupted in pathological conditions. The non-receptor-associated tyrosine kinase fyn is located at the dendrite in neurons, where it was recently shown to interact with tau to stabilise receptor complexes at the post-synaptic density. Fyn also co-localises with tau in a proportion of neurons containing tau tangles in AD and fyn is also a tau kinase. Hence, tau-fyn interactions could play a pathogenic role in AD. Here we report the identification of critical proline residues, Pro213, Pro216, and Pro219, located within the fifth and sixth Pro-X-X-Pro motifs in the proline-rich region of tau, that are important for its binding to fyn. These residues in tau are flanked by numerous phosphorylation sites and therefore we investigated the relationship between fyn and the degree of tau phosphorylation in human post-mortem brain tissue. We found no difference in the amount of fyn present in control and AD brain. Notably, however, there was a significant correlation between fyn and phosphorylated tau at specific phospho-epitopes in control, but not in AD brain. Our results suggest that the pathological mechanisms underlying AD, that result in increased tau phosphorylation, may disrupt the physiological relationship between tau phosphorylation and fyn. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-016-0317-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4870772
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48707722016-05-19 Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease Lau, Dawn H. W. Hogseth, Marte Phillips, Emma C. O’Neill, Michael J. Pooler, Amy M. Noble, Wendy Hanger, Diane P. Acta Neuropathol Commun Research Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterised by neuropathological deposits of amyloid plaques and neurofibrillary tangles comprised of β-amyloid and tau protein, respectively. In AD, tau becomes abnormally phosphorylated and aggregates to form intracellular deposits. However, the mechanisms by which tau exerts neurotoxicity in disease remain unclear. Recent studies have suggested that the presence of tau at synapses may indicate a role in neuronal signalling, which could be disrupted in pathological conditions. The non-receptor-associated tyrosine kinase fyn is located at the dendrite in neurons, where it was recently shown to interact with tau to stabilise receptor complexes at the post-synaptic density. Fyn also co-localises with tau in a proportion of neurons containing tau tangles in AD and fyn is also a tau kinase. Hence, tau-fyn interactions could play a pathogenic role in AD. Here we report the identification of critical proline residues, Pro213, Pro216, and Pro219, located within the fifth and sixth Pro-X-X-Pro motifs in the proline-rich region of tau, that are important for its binding to fyn. These residues in tau are flanked by numerous phosphorylation sites and therefore we investigated the relationship between fyn and the degree of tau phosphorylation in human post-mortem brain tissue. We found no difference in the amount of fyn present in control and AD brain. Notably, however, there was a significant correlation between fyn and phosphorylated tau at specific phospho-epitopes in control, but not in AD brain. Our results suggest that the pathological mechanisms underlying AD, that result in increased tau phosphorylation, may disrupt the physiological relationship between tau phosphorylation and fyn. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-016-0317-4) contains supplementary material, which is available to authorized users. BioMed Central 2016-05-18 /pmc/articles/PMC4870772/ /pubmed/27193083 http://dx.doi.org/10.1186/s40478-016-0317-4 Text en © Lau et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Lau, Dawn H. W.
Hogseth, Marte
Phillips, Emma C.
O’Neill, Michael J.
Pooler, Amy M.
Noble, Wendy
Hanger, Diane P.
Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease
title Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease
title_full Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease
title_fullStr Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease
title_full_unstemmed Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease
title_short Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer’s disease
title_sort critical residues involved in tau binding to fyn: implications for tau phosphorylation in alzheimer’s disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870772/
https://www.ncbi.nlm.nih.gov/pubmed/27193083
http://dx.doi.org/10.1186/s40478-016-0317-4
work_keys_str_mv AT laudawnhw criticalresiduesinvolvedintaubindingtofynimplicationsfortauphosphorylationinalzheimersdisease
AT hogsethmarte criticalresiduesinvolvedintaubindingtofynimplicationsfortauphosphorylationinalzheimersdisease
AT phillipsemmac criticalresiduesinvolvedintaubindingtofynimplicationsfortauphosphorylationinalzheimersdisease
AT oneillmichaelj criticalresiduesinvolvedintaubindingtofynimplicationsfortauphosphorylationinalzheimersdisease
AT pooleramym criticalresiduesinvolvedintaubindingtofynimplicationsfortauphosphorylationinalzheimersdisease
AT noblewendy criticalresiduesinvolvedintaubindingtofynimplicationsfortauphosphorylationinalzheimersdisease
AT hangerdianep criticalresiduesinvolvedintaubindingtofynimplicationsfortauphosphorylationinalzheimersdisease